Oxurion Company
At Oxurion we are dedicated to developing innovative treatments to preserve vision for patients with diseases affecting the back of the eye. The company has built a diverse portfolio of disease-modifying therapies, including treatments for diabetic eye disease, a leading cause of blindness in people of working age worldwide.
Industry:
Small&Large Molecules
Headquarters:
Heverlee, Vlaams-Brabant, Belgium
Founded Date:
1991
Register and Claim Ownership